Spatially resolved fetal and maternal cell contributions to severe preeclampsia across gestation
Science Advances · 24.07.2026 · 12 (30)
DOI: 10.1126/sciadv.aed8964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 24.07.2026. Verfasst von Yara E Sanchez-Corrales und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetics and Genomic Medicine Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK. Hauptthemen laut MEDLINE: Pre-Eclampsia, Placenta, Fetus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Kennedy Trust for Rheumatology Research, Medical Research Council, NIHR GOSH Biomedical Research Center.
Abstract (Originalsprache)
The molecular and cellular pathophysiology of preeclampsia remains poorly understood, but it is increasingly clear that in addition to the placenta, other tissues of the fetal-maternal interface advance the disease. Here, we distinguish fetal and maternal contributions to the early and late presentation of severe preeclampsia by interrogating, across time and space, tissues and cell types relevant to the disease. Accounting for gestational age in a third trimester preterm cohort, we find single-cell and spatial molecular signatures of concerted hypoxia, angiogenic imbalance, fibrosis, and aberrant metabolism in the placenta. In addition, we report maternal immune signatures such as mitochondrial dysfunction and interferon signaling extending to the myometrium and chorioamniotic membranes, likely contributing to the systemic inflammation and endothelial dysfunction in the mother, with impaired fetal cell interactions with endothelial cells in the myometrium contributing to it. These tissue- and cell-specific responses are potential targets for therapy, with their prompt consideration in early gestational disease likely beneficial because of its aggravated molecular presentation. Thus, timely intervention during gestation could change the extremely poor prognosis of severe preeclampsia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Genetics and Genomic Medicine Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
- UCL Genomics, UCL Great Ormond Street Institute of Child Health, London, UK.
- Department of Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
- Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCL Hospitals and GOSH, London, UK.
- Department of Ageing, Rheumatology and Regenerative Medicine, UCL Division of Medicine, UCL, London, UK.
- Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
ORCID-Profile: Yara E Sanchez-Corrales, Theodoros Xenakis, Jose J Moreno-Villena, Leysa Forrest, Neil J Sebire, Elizabeth C Rosser, Sara L Hillman
Förderung
- Kennedy Trust for Rheumatology Research
- Medical Research Council
- NIHR GOSH Biomedical Research Center
- Catalyst Fellowship
Zitieren
APA
Sanchez-Corrales, Y. E., Xenakis, T., Moreno-Villena, J. J., Forrest, L., Sebire, N. J., Rosser, E. C., Wedderburn, L. R., Castellano, S., & Hillman, S. L. (2026). Spatially resolved fetal and maternal cell contributions to severe preeclampsia across gestation. Science Advances, 12(30). https://doi.org/10.1126/sciadv.aed8964
Vancouver
Sanchez-Corrales YE, Xenakis T, Moreno-Villena JJ, Forrest L, Sebire NJ, Rosser EC, et al. Spatially resolved fetal and maternal cell contributions to severe preeclampsia across gestation. Science Advances. 2026;12(30). doi:10.1126/sciadv.aed8964
BibTeX
@article{SanchezCorrales2026,
author = {Sanchez-Corrales, Yara E and Xenakis, Theodoros and Moreno-Villena, Jose J and Forrest, Leysa and Sebire, Neil J and Rosser, Elizabeth C and Wedderburn, Lucy R and Castellano, Sergi and Hillman, Sara L},
title = {Spatially resolved fetal and maternal cell contributions to severe preeclampsia across gestation},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {30},
doi = {10.1126/sciadv.aed8964}
}
EUVIMED